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Abstract
Applications utilising 3D Camera technologies for the measurement of health outcomes in the health and wellness sector
continues to expand. The Intel® RealSense™ is one of the leading 3D depth sensing cameras currently available on the market
and aligns itself for use in many applications, including robotics, automation, and medical systems. One of the most prominent
areas is the production of interactive solutions for rehabilitationwhich includes gait analysis and facial tracking. Advancements in
depth camera technology has resulted in a noticeable increase in the integration of these technologies into portable platforms,
suggesting significant future potential for pervasive in-clinic and field based health assessment solutions. This paper reviews the
Intel RealSense technology’s technical capabilities and discusses its application to clinical research and includes examples where
the Intel RealSense camera range has been used for the measurement of health outcomes. This review supports the use of the
technology to develop robust, objective movement and mobility-based endpoints to enable accurate tracking of the effects of
treatment interventions in clinical trials.
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Introduction
There are an increasing number of 3D camera-based technol-
ogies in today’s market generating a large number of techno-
logical solutions in many different sectors. Finding a unique
application is therefore becoming even more difficult whether
it be related to 3D scanning, motion capture, gaming,
wellbeing applications or clinical and healthcare research.
The rapid development of 3D camera technologies has result-
ed in a market with numerous options, all with varying
strengths and weaknesses. Therefore, camera selection is crit-
ical dependant on the desired application. Some of the most
notable solutions include the Microsoft® Kinect™1 Sensor
V1/1.0 (360), Microsoft Kinect Sensor V2/2.0 (One)
(Microsoft Corp., Redmond, Washington, USA), Intel
RealSense 3D Camera range, Intel® Euclid™ (Intel Corp.,
Santa Clara, CA, USA), Creative Senz3D (Creative
Technology Ltd., Singapore) Asus Xtion Pro Live (AsusTek
Computer Inc., Beitou District, Taipei, Taiwan), OptiTrack
MoCap (NaturalPoint, Inc., USA), Vicon Infineon 3D Image
Sensor (REAL3™ Gesture Control) (Vicon Motion Systems
Ltd., Oxford, UK) and ZED Stereo Camera (Stereolabs Inc.
San Francisco, CA, USA).
The Intel RealSense is one of the most prominent 3D depth
sensing cameras available, and especially now, considering
the recent announcement that manufacture of the Microsoft
Kinect Sensor V2/2.0 has now ceased - potentially signalling
the end of Microsoft’s involvement in this technology sector
1 Microsoft ® Corporation, Redmond, Washington, USA, https://www.
microsoft.com
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[1]. Although Kinect support will continue to exist in the
interim for the motion-sensing device, the limited access to
purchase this technology will likely signal a change in the
adoption and use of this motion sensing device for new devel-
opment applications.
Application to clinical research
There are numerous applications utilising motion capture
technology to study or encourage movement in wellness,
healthcare and clinical research. Much of this work has been
accomplished in the area of rehabilitation to provide an en-
gaging environment through which to conduct a regular exer-
cise regimen. This enables patient feedback and correction to
ensure that exercises are being performed correctly for optimal
benefit, and enables remote assessment and adjustment of ex-
ercise regimens between clinic visits [2].
In clinical research and clinical drug development, the
study of movement and mobility can be a vital component
of understanding the impact of an intervention. This is typi-
cally assessed by clinician rating or using an instrumented
solution to provide an objective measurement. Many instru-
mented solutions to assess motion and mobility, such as the
Vicon 3D motion analysis system (Vicon Motion Systems
Ltd., Oxford, UK) or the GAITRite™ pressure pad system
(CIR systems Inc., Franklin, NJ, USA) are expensive to use
and may be confined to specialist assessment centres, limiting
their use in large-scale clinical trials.
Low-cost, reliable 3D camera technology may provide a
means to collect rich objective data in non-specialist centres in
large clinical trials. Application areas may include: assessment
of gait and upper extremity movement (e.g., in stroke pa-
tients); walking, upper extremity and dexterity tests (e.g., in
multiple sclerosis); walking, posture and balance testing (e.g.,
in Parkinson’s disease); and other indications or side-effects
where objective measures of movement or mobility are im-
portant to how patient’s function such as: amyotrophic lateral
sclerosis, tardive dyskinesia, Huntington disease, depression
(where gait is indicative of mood status), restless leg syn-
drome, Bell’s (facial) palsy, muscular dystrophies and rheu-
matoid diseases amongst many others.
Properties of the Intel RealSense camera
relevant to clinical research applications
The Intel® RealSense™ camera utilises a variety of sensing
technologies to achieve depth perception, 3D imaging, interior
mapping, and feature tracking. Intel present a variety of uses
for the Intel® RealSense™, which considers virtual reality,
robotic vision development, drones, security, 3D scanning
and tracking, amongst others. Intel have developed a range
of camera systems which can be integrated into a variety of
platforms including PC’s, laptops, 2-1 Laptop/PC’s, external
camera systems, smartphones and tablets.
A number of the capabilities of these camera systems, and
those produced by other manufacturers are particularly impor-
tant to consider when creating applications for clinical re-
search; a selection of these are described in Table 1.
All of the 3D camera’s that utilise Intel's RealSense software
development kits (SDKs) enable the development of natural,
immersive, and intuitive software applications utilising routines
that include but that are not limted to, facial recognition, hand
gesture, background removal, 3D scanning and skeletal tracking.
Another recent addition to the market is the Intel Euclid™
Development Kit. This utilises an Ubuntu® (Canonical Ltd.,
London, UK) operating system integrated with Intel RealSense
depth camera technology in combination with an Intel®Atom™
×7-Z8700QuadCore CPU providing a compact and sleek all-in-
one computer and depth camera system [3].
Facial tracking
The Intel RealSense camera range can be used to scan and
track facial features and gestures with and without facial hair
and glasses. It has the ability to 3D track up to 78 facial
landmark points that can support avatar creation, emotion rec-
ognition and facial animation [4]. The Intel RealSense can
also detect head orientation along 3D axes for yaw, pitch
and roll. Depending on the camera in use the ability to track
up to four faces with marked rectangles for face boundaries is
achievable. For systems where the environment cannot be
controlled this is extremely useful as it would allow the indi-
vidual patient to be identified and solely tracked. The Intel
RealSense camera range can offer greater resolution and sam-
pling rates compared to some of the current market leaders,
including the Microsoft Kinect 2.0. The greater resolution and
sampling rate offer advantages when tracking fine or fast
movements.
Skeletal tracking
The Intel RealSense can also perform skeletal tracking. By
tracking the 3D coordinates of body joints, the Intel
RealSense can create a virtual skeleton allowing the calcula-
tion of patient movement parameters and joint angles. This
real-time tracking enables the development of applications in
a number of key areas. Tracking a user’s skeletal movement
during a routine exercise or while playing a game opens up the
ability to detect subtle improvements during rehabilitation
from injury or stroke. In the past this has been done by placing
sensors on the user’s body at key locations, or using complex
multi-camera systems, and the transmitting data to a connect-
ed machine for analysis. These setups are often expensive,
inconvenient and difficult to use in non-specialist settings. In
addition, joint tracking can enable the measurement of body
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movement attributes such as gait parameters, body sway and
balance while the patient is conducting simple performance
tests in front of the camera. The ability to conduct these
tests simply in small spaces and without attaching sensors or
instruments to the patient increases the utility of this approach.
Intel RealSense camera SR300, R200 & F200
The Intel RealSense SR300 is a short range, coded light 3D
imaging system and is one of the smallest 3D depth and 2D
camera modules currently available on the market. The Intel
RealSense SR300 combines depth sensing with a 1080p RGB
camera, this provides users the opportunity to work with dy-
namic background segmentation, 3D scanning, facial recog-
nition and hand gesture recognition. The Intel RealSense
SR300 camera is ideal for face analytics and tracking, scan-
ning and mapping, scene segmentation, hand and finger track-
ing and augmented reality. This is completed through the
utilisation of an infrared (IR) projector and IR camera in tan-
dem using coded light patterns [5].
The Intel RealSense Camera R200 is a USB 3.0 world-
facing camera system that can provide colour, depth, and infra-
red video streams which can be utilised alongside various sup-
ported systems such as an Ultrabook™, 2-in-1, All-in-One, or
mobile platforms (i.e. smart phones and tablets) [6]. The R200
has a full HD colour camera and IR depth sensing features. Its
three cameras provide RGB (colour) and stereoscopic IR to
produce depth. The R200 consists of an infrared laser projection
system, two infrared and full HD colour imaging sensors. The
depth video stream is generated using stereo vision technology
which is assisted by the infrared laser projector and the two
infrared imaging sensors [7]. The R200 system provides the
capability to manipulate filters through varied options including
parallax, dolly zoom, motion affects, object segmentation, col-
our popping, and others [8]. Digitally capturing people or ob-
jects in a 3D world by utilising body scans provides the devel-
oper with the option to build 3D printable object and compo-
nents, including the ability to create and manipulate
personalised avatars. The creation of 3D objects or avatars pro-
vides objects that can be incorporated into real-world applica-
tions and spaces which can aid visualisations [8]. The use of
avatars has often been used in rehabilitation systems where
patients may not like to see themselves after suffering a tempo-
rary or permanent physical disability.
The Intel RealSense range has progressively improved over
recent years, and this is noticeable especially in the quality of
motion capture, camera capabilities and field of view ranges.
A full comparison of the general features of the SR300, R200
and F200 systems can be found in Table 2.
The Intel RealSense SDK, SDK components and depth
camera managers for the F200, SR300, and R200 versions
are no longer being updated due to the introduction of newer
versions of the camera range [10], as described below. A full
comparison of the SDK algorithm operating ranges and appli-
cations can be found in Table 3.
The 3D facial tracking capabilities of the Intel RealSense
SDK have some important properties that assist with the de-
velopment of robust and reliable applications. These relate to
the ability to provide robust measurements across a range skin
tones, and in the presence of additional objects such as
Table 1 3D camera system properties for consideration when developing clinical research applications
Property Rationale
Field of vision Field and depth of vision define the working area in which the tracking of patient movement can be achieved. The available
working area will define the nature of performance tests that can be developed and measured using the camera system. For
example, simple gait and walking tests will require sufficient depth / field of vision to ensure that at least a full gait cycle can be
captured for a walking subject not attached to a treadmill.
Depth of vision
Sample rate Sample rate is an important consideration to ensure specific movements can be captured to the required level of granularity and
precision. Simple performance tests such as measuring shoulder range of motion may not require high sample rates when tests
are conducted slowly and only the final range of motion angle is required. However, tests in which rapid movements are
conducted, such as the evaluation of movement from toe off to heel strike during walking will require higher sampling rates for
accurate estimation.
Resolution Higher resolution is important in the tracking and measurement of more detailed movement, such as facial analysis or hand joint
movements.
Skeletal tracking Accurate and reliable tracking of 3D joint coordinates is the basis for many rehabilitation and clinical research applications
requiring the measurement of body movements and balance.
Facial tracking Accurate 3D tracking of facial landmarks enables the tracking andmeasurement of a number of aspects of facial movement such as
facial paralysis recovery after stroke / Bell’s palsy and assessment of stimulus-related expression in ADHD and autism spectrum
disorders.
Hand and digit
tracking
Tracking of hand and digit movement is important in performance tests of dexterity and potentially in the detection of gross tremor
movements in conditions such as Parkinson’s disease.
Object recognition Object recognition is an important component of accurate landmark tracking where estimates may be affected by the presence of
additional objects within the field of vision. Object detection is used extensively with face detection and recognition (e.g.,
detection of glasses, piercings or facial hair), and in skeletal tracking (e.g., presence of a chair or walking support).
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piercings or glasses. Facial hair is another factor which can
drastically alter the tracking capabilities, however the Intel
RealSense SDK can combat this. Obstructions can also greatly
affect the tracking capabilities of numerous camera tracking
technologies; common movements such as yawning,
scratching of the face etc., can affect tracking and data acqui-
sition; the Intel RealSense camera range can also take this into
consideration and continue to accurately track.
Variable lighting conditions can adversely affect the quality of
the tracking and has been noted in the past to seriously affect the
tracking of facial landmarks; this has been especially noted with
the Microsoft Kinect [12]. Vision based tracking methods often
perform better in controlled environments with limited variables
such as skin tone, clothing colour and shape, lighting level, po-
sition and restricted background clutter. Utilising this technology
in the home for health measurement can be problematic for re-
mote users where the environment may not be ideal [12]. The
Intel RealSense, however performs well in low light environ-
ments where other solutions continue to struggle but with huge
variances in light intensity still being problematic.
Wearing glasses, in some situations can have an adverse
effect on the tracking of the face. This is especially noted with
2D tracking where glasses can significantly affect the size of
the eyes which often become amplified by the lenses, thus
providing false tracking data (Fig. 1). In the presence of
glasses, 2D images may result in loss of landmark tracking,
Table 3 Intel RealSense F200, R200 & SR300 Camera Algorithm Operating Ranges [11]
Intel RealSense F200 Intel RealSense R200 Intel RealSense SR300
Facial Tracking
Detection 30-100 cm 55-250 cm 30-100 cm
Landmark 30-100 cm 50-150 cm 30-100 cm
Recognition 30-80 cm 30-150 cm 30-150 cm
Expression 30-100 cm 30-100 cm 30-100 cm
Pulse 30-60 cm 30-70 cm 30-60 cm
Pose 30-100 cm 50-150 cm 30-100 cm
Hand Tracking
Hand Segmentation 20-80 (1 m/s) NA 20-110 (1.5 m/s)
Hand Tracking 20-60 (0.75 m/s) NA 20-85 (1 m/s)
Hand Gesture Tracking 20-60 (0.75 m/s) NA 20-85 (1 m/s)
Generic Tracking Features
Object Tracking 30-180 cm No 30-180 cm
Person Detection No 70-350 cm 50-250 cm
Person Tracking No 70-500 cm 50-500 cm
Skeleton Tracking No 100-250 cm 50-200 cm
Skeletal Joint Tracking * No Yes Yes
* Skeletal joint tracking no longer supported by Intel RealSense SDKs
Table 2 Intel RealSense F200, R200 & SR300 Generic Feature Comparison [9]
Intel RealSense F200 Intel RealSense R200 Intel RealSense SR300
RGB Camera (Pixel) 1080p at 30 FPS 1080p at 30 FPS 1080p at 30 FPS, 720p at 60 FPS
Depth Camera (Pixel) Up to 640 × 480 at 60 FPS
(Fast VGA, VGA), HVGA at 110 FPS
640 × 480 resolution
at 60 FPS
Up to 640 × 480 at 60 FPS
(Fast VGA, VGA), HVGA at 110 FPS
RGB Colour Field Of View 43o,70o,77o 77°×43°×70° 41.5o,68o,75.2o
Infrared Field Of View 59o,73o,90o 70°×46°×59° 55°×71.5°×88°
Approx. price (USD)* 140 180 110
SDK Status Discontinued Discontinued SDK 2.0 Capable & Support Active (GitHub)
3D Camera Features
Effective Range 0.2 m – 1.2 m 0.4 m to 2.8 m 0.2 m – 1.2 m
Texture Mapping Yes Yes Yes
World Mapping Yes Yes Yes
Person Tracking No Yes Yes
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as shown by the black tracking points on the 2D camera image
in Fig. 1. This affects the ability to measure and detect actions
such as blinking and winking. The use of 3D tracking utilising
the SR300 camera in this example is unaffected by the lenses
and the frames of the glasses; the tracking points clearly plot
the position of the eyes which adjusts based on whether the
eyes are open or closed.
Variance in lighting and colour can also have an effect on
facial tracking. A good example of this is when a subject
wears tinted glasses. When utilising 2D tracking the camera
is no longer able to track the subject’s eyes and tries to predict
where the eyes would be located as a result of the other land-
mark points. Yet when using 3D camera tracking, the system
is able to calculate the location of the eyes accurately thus
tracking is unaffected (Fig. 2).
Intel RealSense camera ZR300, D415 & D435
As the demand for the Intel RealSense and SDK development
has advanced, there has become a greater demand for both
short and long range depth sensing cameras resulting in the
development of the Intel RealSense Cameras ZR300, D415 &
D435.
The ZR300 includes a high resolution depth camera which
has an integrated robust motion tracking module. The ZR300
has scope for various applications due to its high resolution
depth sensing, highly robust tracking, long-range support, in-
door and outdoor use, and low power usage. The indoor range
of the camera is approximately 0.5-3.5 m with an outdoor
range capable of reaching significantly greater distances.
However the range supported does vary depending on the
light conditions and environment [13]. The Intel RealSense
Development Kit ZR300 is seen as an ideal solution for edu-
cation platforms, hardware prototyping and software develop-
ment amongst other possible solutions. The ZR300 also has
the capability to enable 3D spatial perception using motion
tracking, depth perception, and area learning. Most important-
ly, the ZR300 has a high frame rate which enables tracking
performance for 3D scanning applications and rapid motor
movements [13]. Table 4 demonstrates that the ZR300 is su-
perior to the SR300; however, the pre-release of the D415 &
D435 (Available in Q1 2018) also demonstrates further
advancements.
Intel have recently launched a new D400 camera range that
presents the most advanced depth perception capabilities to
date. The D415 & D435 depth sensing cameras contain the
Fig. 2 2D (RGB Camera) v 3D
(Intel SR300 Camera) Tracking –
Tinted Glasses
Fig. 1 2D (RGB Camera) v 3D
(Intel SR300 Camera) Tracking –
Glasses
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latest Intel RealSense vision processor and module. The addi-
tion of the rolling image shutter and standard field of view, the
Intel RealSense Depth Camera D415 offers a general-purpose
solution with simple depth stream data capture. However, the
D435 offers a global image shutter and wider field of view
with the capability to capture and stream the depth data of
moving objects thus, providing high depth perception accura-
cy inmotion [16]. In comparison to earlier versions of the Intel
RealSense Camera range the optimal environment for the
D400 series has been significantly increased with data capture
possible at distances up to and in excess of 10m in both indoor
and outdoor environments [16].
Application to clinical research
Clinical trials employ a variety of approaches to measure the
health status of patients and changes in their health due to
treatment. In many therapy areas, subjective ratings made by
the patient (patient reported outcome measures – PROs) or by
a clinician (clinician reported outcome measures – ClinROs)
are used to measure status or change over time. Patient report-
ed outcomes measures, such as a daily symptom diary or a
quality of life questionnaire importantly measure the perspec-
tive of the patient regarding the effects of treatment, and in
some cases (e.g. pain assessment) may be the only way to
assess efficacy. ClinROs include measures of symptoms
through direct observation of the patient. For example, depres-
sion symptoms and severity may be rated by a trained clini-
cian following a structured interview using the Hamilton
Depression Rating Scale. A further clinical outcome assess-
ment, the performance outcome (PerfO), is a measurement by
a healthcare professional based upon observation of a task
performed by the patient. In many cases these PerfOs are
measured using subjective assessments. Quite a number of
subjective measurement scales are used in clinical trials to
assess balance, movement or mobility based on observation
of the patient conducting a specified movement or activity.
Subjective ratings (e.g. assessing the patient using a verbal
response scale) are not very sensitive to detecting small im-
provements, and different investigators may rate patients dif-
ferently based upon their interpretation of the scale require-
ments. For this reason it is sometimes difficult to make mea-
surements that are sensitive enough to detect treatment-related
changes and are able to conclusively show treatment effects
when they exist. In addition, using investigator observation it
is less likely that detailed or subtle aspects of movement and
mobility can be recorded. Where these can be replaced by
objective measures, this may result in a greater ability to iden-
tify changes due to treatment.
There is a growing body of applications leveraging depth
camera platforms to provide applications in healthcare. Much
of this work to date has been conducted using Microsoft
Kinect and the depth camera utilised within the Microsoft X-
box gaming platform. Reasons for this include the low cost
and availability of the hardware, the ability to connect to a
Windows computer, and the free availability of its SDKwhich
contains skeletal tracking (Fig. 3) and facial analysis modules.
The majority of healthcare applications reported using
Microsoft Kinect are applied to the area of rehabilitation, in-
cluding novel ways of engaging patients in regular exercise
regimens and solutions to ensure that exercises are performed
correctly for optimal outcomes. Published examples apply to a
number of disease indications including stroke [17],
Parkinson’s disease [18], Multiple Sclerosis [19] and
Cerebral Palsy [20].
While many published applications fall short of measuring
and reporting specific health outcomes, there are examples of
Table 4 Intel RealSense SR300, ZR300, D415 & D435 Generic Feature Comparison [14–16]
IntelRealSense SR300 Intel RealSense ZR300 Intel RealSense D415 IntelRealSense D435
RGB Camera (Pixel) 1080p at 30 FPS, 720p at 60 FPS 2MP, Up to 1080p
@ 30 FPS
1920 × 1080 at 30 FPS 1920 × 1080 at 30 FPS
Depth Camera (Pixel) Up to 640 × 480 at 60 FPS
(Fast VGA, VGA), HVGA at 110 FPS
Up to 628 × 468
@ 60 fps
Up to 1280 × 720 at up
to 90 FPS
Up to 1280 × 720
at up to 90 FPS
Depth Field of View (FOV) 55°×71.5°×88° 70° × 46° × 59° 69.4°×42.5°×77° 91.2°×65.5°×100.6°
RGB Colour Field
Of View
41.5ox68ox75.2o 75° × 41.5° × 68° 69.4°×42.5°×77° 69.4°×42.5°×77°
Effective Depth Range 0.2 m – 1.2 m 0.5 – 3.5 m + 0.3 – 10 m + 0.2 – 10 m +
Typical Environment Of Use Indoor Indoor & Outdoor Indoor & Outdoor Indoor & Outdoor
Face Tracking & Recognition Yes Yes Yes Yes
Expression Recognition Yes Yes Yes Yes
Gesture Recognition Yes Yes Yes Yes
Hand Tracking Yes Yes Yes Yes
Approx. price (USD)* 110 289 149 179
* Prices as of November 2017
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applications built using the Kinect platform that report health
outcome measures that may enable the longitudinal tracking
of change and the formal assessment of treatment benefits. We
provide a good summary of published applications measuring
aspects of gait and balance, upper extremity movement, and
chest wall motion elsewhere [2, 21].
Published clinical research applications using the Intel
RealSense camera
Less work is available in the published literature on clinical
research applications using the Intel RealSense camera range,
although this is emerging and likely to increase for the reasons
cited earlier in this article. In the absence of a significant body
of work, we present some examples below, as opposed to a
formal systematic review.
Chhor et al. [22] report the development and preliminary
use of a computer game leveraging the Intel RealSense camera
to assist upper body rehabilitation and exercising using de-
fined hand gestures and movements. Ferche et al. [23] used
the Intel RealSense camera to provide precise tracking of the
movements of the human hand within a neuromotor rehabili-
tation application, and Baldominos et al. [24] and Cidota et al.
[25] leveraged the Intel RealSense camera within a rehabilita-
tion system focussed on upper extremity movement.
House et al. [26] utilised the SR300 camera in the evalua-
tion of its use for image-guided interventions and application
in vertebral-level localization. Silver et al. [27] also utilised
the facial tracking capabilities of an Intel RealSense camera in
the production of a happiness and sadness recognition system.
Bandini et al. [28] also produced a video-based tracking sys-
tem utilising the SR300 to capture jaw movements during
speech which may be utilised in various health measurement
tasks such as the assessment, diagnosis and treatment of var-
ious speech disorders.
The Intel RealSense cameras have also been integrated into
smart systems which utilise additional hardware. One example
in health research utilises the cameras to produce a 3D full-
body scan in combination with the Intel® Edison™module to
provide additional peripheral device communication via
Bluetooth and Wi-Fi [29].
Translating outcome data into acceptable
trial endpoints
As researchers continue to develop applications using 3D
camera technology for use in clinical research, it is important
to be cognisant of the requirements associated with the evi-
dence needed to support the use of technology, and the clinical
endpoints derived for use, in regulatory clinical trials and new
drug applications. In clinical trials, a study endpoint is defined
as a characteristic or variable that reflects how a patient feels,
functions, or survives [30]. An endpoint description includes
information defining how and when they are measured, how
they are calculated, rules for missing data and how they are
analysed. In the absence of formal regulatory guidance, the
Critical Path Institute’s ePRO Consortium reported consensus
recommendations on the evidence required to support wear-
able device selection and endpoints derived from wearables
data [31]. These recommendations have strong parallels to the
requirements in defining clinical endpoints for regulatory drug
submissions arising from outcomes data collected using
motion-based cameras.
In essence, it is important to demonstrate the reliability and
validity of outcomes data collected using a motion-based plat-
form; and to demonstrate the suitability and interpretability of
endpoint measures derived from this data.
Reliability
Intra- and inter-device reliability should be demonstrated by
assessment of test-retest reliability using the same and differ-
ent units of the same device. Typically this will be assessed
Fig. 3 Tracking the 3D position of 26 body joints using Microsoft Kinect
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using the Intraclass Correlation Coefficient (ICC). To ensure
reliability is maintained, camera manufacturers must be able
to demonstrate that devices are produced in adherence with a
quality system to ensure equivalence of devices between
batches and with the reliability data provided. Changes to
the SDK affecting the detection of 3D coordinates of body
joints will require re-assessment of reliability should software
upgrade to leverage the revised SDK.
Concurrent validity
Concurrent validity is important to demonstrate that the ap-
proach is truly measuring what is intended. This is typically
performed by comparing results to a gold standard methodol-
ogy that is regarded as an accurate measure of the concept of
interest. For example in the case of body movement, a gold
standard could be the VICON camera system. A small study
of human subjects should enable this to be evaluated.
Content validity
It is important to demonstrate that the endpoint(s) derived are
considered important to patients and a relevant outcome with-
in the disease/treatment studied. This content validity can be
obtained through qualitative data collection in patients or oth-
er reporters such as physicians or carers. Some outcomes mea-
sures generated by depth camera software may already be well
known and understood, and in these cases content validity
may be already established.
Ability to detect change
Outcome measures and derived endpoints should, when used
in a clinical trial be seen to be sensitive enough to detect
change when a change exists. This is normally demonstrated
by controlled studies involving an intervention that is under-
stood to create a change in the outcome of interest.
Endpoint interpretability
For an endpoint to be suitable for use in a clinical drug submis-
sion it is important to understand meaningful change. In other
words, it should be understood what degree of change in the
endpoint can be interpreted as clinically relevant to the patient.
This may be represented by the minimal important difference
(MID) or minimally clinically important difference (MCID), or
the minimal individual change that distinguishes a responder
from a non-responder. There are well established methodolo-
gies used to estimate MCID and responder definition [31].
Discussion and conclusions
The Intel RealSense has considerable potential for research so-
lutions and platforms. Its versatility enables integration into a
variety of platforms while remaining a low-cost solution. To
date the most popular 3D motion sensing camera technologies
utilised within research and development are the Microsoft
Kinect 1.0 & 2.0 (X-Box 360 and X-Box One Kinect). The
popularity of the Microsoft Kinect 1.0 & 2.0 is not surprising
due to the constant development of the SDK’s and gaming
applications, this has resulted a discontinuation of a number
of 3D camera technologies over the past 10 years. However,
the emergence of the Intel RealSense camera range provides an
alternative, which the authors believe has comparable and su-
perior technical functionality. The Intel RealSense range is cur-
rently in its infancy yet expanding quickly with an ever-
improving camera and increasingly extensive SDK. The Intel
RealSense system can be seen as a comparable if not superior
alternative to theMicrosoft Kinect due to its 3D scanning, facial
recognition and hand gesture recognition capabilities and there-
fore this is seen as suitable technology for research and devel-
opment within the healthcare sector. In addition, with recent
announcement that the manufacture of the Microsoft Kinect
Sensor V2/2.0 has now ceased [1], potentially signalling the
end of Microsoft’s involvement in this technology sector, the
Intel RealSense camera range is best placed to take advantage
within the clinical and healthcare sector.
The associated SDK is currently the area which limits the
full utility of the Intel RealSense camera range. However, as the
product is very much in its infancy, this is expected to become
more extensive over time. Using the facial tracking abilities of
the Intel RealSense, researchers can develop systems that can
track a user’s emotions, this can not only be useful for medical
products that utilise the camera within the project itself but also
for measuring the user acceptability on projects not utilising the
camera [32]. Research has also been performed to analyse the
feasibility of using skeletal tracking to detect a user’s emotional
state based upon their walking gait [33].
The facial and hand tracking abilities of the RealSense can
be used to allow a user to interact with the world around them
using only small motions. There are many systems utilising
the facial and hand tracking capabilities of the Microsoft
Kinect such as the Face Controller system for patients with
disabilities developed by Risenbit [34]. Patients with limited
mobility often require systems to be designed for them to
facilitate their disability thus allowing them to perform daily
activities such as typing on a keyboard [34]. The best known
of these types of systems is the wheelchair used by Professor
Stephen Hawking, this has been designed and developed by
Intel and currently utilises an IR sensor to detect cheek move-
ments that allow the user to type on a keyboard. Using facial/
hand tracking this could be implemented for other users
allowing the utilisation of customisable facial or hand gestures
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and potentially increasing the number of controls available by
monitoring multiple areas of the face/hands.
The Intel RealSense camera allows for skeletal hand tracking
of 25 tracked body joints, the potential for medical applications
range from tracking the full body motion, balance and tracking
dexterity and handmovements such as tracking and monitoring
a patient with Parkinson’s disease to detect deterioration or
improvement in the patient’s condition [35]. Full hand skeletal
tracking can be used to track both hands while a patient per-
forms sign language this can then be interpreted and translated
for use with typing and voice synthesisers [36]. As depth cam-
era technology becomes more advanced and the components
become smaller we are seeing a number of other manufacturers
entering the depth camera market and implementing them into
mobile phones and tablets. This includes Apple's iPhone Xwith
a depth camera used for facial recognition and tracking.
Qualcomm (Qualcomm Incorporated, San Diego, California,
USA) have also announced their Spectra™ ISP 2nd generation
Module which incorporates high-resolution depth sensing with
over 10,000 points of depth for motion tracking. This impor-
tantly opens the possibility of developing applications to deliver
performance testing remotely and more frequently without the
need for patients to visit clinical sites for assessments.
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